CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: TGF-β1 may promote the apoptosis of the CD34 and CD34-DR cells of patients with chronic myeloid leukemia; however, it does not increase the expression of the CD95 Fas receptor in leukemia cells.